Correlation Between Regenxbio and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Cardiff Oncology, you can compare the effects of market volatilities on Regenxbio and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Cardiff Oncology.
Diversification Opportunities for Regenxbio and Cardiff Oncology
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Regenxbio and Cardiff is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Regenxbio i.e., Regenxbio and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Regenxbio and Cardiff Oncology
Given the investment horizon of 90 days Regenxbio is expected to under-perform the Cardiff Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.23 times less risky than Cardiff Oncology. The stock trades about -0.05 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 211.00 in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of 30.00 from holding Cardiff Oncology or generate 14.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Regenxbio vs. Cardiff Oncology
Performance |
Timeline |
Regenxbio |
Cardiff Oncology |
Regenxbio and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and Cardiff Oncology
The main advantage of trading using opposite Regenxbio and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |